We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: Discontinued Formulation of Protonix IV Is Unsafe for Generics
FDA: Discontinued Formulation of Protonix IV Is Unsafe for Generics
The FDA will not approve generics referring to the original and discontinued formulation of Protonix IV, after a review of scientific data confirmed that therapy for gastroesophageal reflux disease was pulled off the market for safety reasons.